iShares Biotechnology ETF (IBB)
$137.04
0.82 (0.59%)
IBB Stock Quote Delayed 30 Minutes
Buy Bristol-Myers Squibb Co (BMY) Stock With No Fear
BMY is rallying on solid fundamentals to reclaim a long-term pivot levels as support for even higher prices. Go long on strong support.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
649,273
Day's Range
$136.60 - $138.80
52-Week Range
$123.60 - $150.57
Dividend & Yield
$0.40 (0.29%)
IBB Stock Predictions, Articles, and iShares Biotechnology ETF News
Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB) Keeps Generating Alpha
The sound technical backdrop not only in biotech such as the IBB ETF but also in healthcare continues to favor the bulls for the time being.
Gilead Sciences, Inc. (GILD) Stock Still Has Room to Grow
Gilead Sciences was the poster child of a falling knife for two years. Now, we can use a double bottom in GILD stock to generate income.
Trade of the Day: Biogen Inc (BIIB) Stock Is Coiling
BIIB stock is showing a tight chart pattern and thus a great way to define risk for a breakout Biogen setup. Traders take note and get ready.
Trade of the Day: Celgene Corporation (CELG) Stock Flashing Buy Signals
CELG stock bounced off a critical technical support level and Celgene now offers traders a well-defined reward to risk trade to the upside.
Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Quiet Bull
AMGN stock is in consolidation mode but there is still little not to like about Amgen. Those who are patient will ultimately be rewarded.
Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB)
Biotech stocks and the IBB ETF had two so called "bearish engulfing" days in recent trading days. This is a near-term warning signal.
Amgen, Inc. (AMGN) Stock Is a Trade for Ailing Portfolios
Investors fear Amgen (AMGN) is a falling knife after dropping on earnings. Use that fear to sell puts for income in AMGN stock.
Trade of the Day: Amgen, Inc. (AMGN) Stock Is a Standout
AMGN stock rallied 1% on Wednesday, and while no major feat in percentage terms, on the charts Amgen looks constructively positioned.
Dipping Celgene Corporation (CELG) Stock Is Begging to Be Bought
Biotech stocks, including Celgene, are pulling back. CELG stock is one of the best dip-buying opportunities of the bunch.
Play the Sector Rotation Game
Plenty of risk headlines, from political to geopolitical, continue to be thrown at this market, yet the trajectory remains higher and the sector rotation game reigns.
Play the iShares Nasdaq Biotechnology Index (ETF)’s (IBB) Popularity for Free
ETFs should not move 11% in four days. The IBB just did that, so I will short it with no money out of pocket. Bet against the herd mentality.
Is the SPDR S&P Biotech (ETF) (XBI) Done Running?
Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading.
This Market’s Biggest Problem? Energy.
As oil prices continue to languish, energy stocks keep weighing the S&P 500 down and disappointing investors.
Don’t Be Scared of Biogen Inc (BIIB) Stock
Pharma stocks like Biogen (BIIB) scare most investors. That means you can sell downside risk against unlikely scenarios in BIIB stock.
Trade of the Day: iShares Nasdaq Biotechnology Index (ETF) (IBB)
The past two trading days of risk-on in the IBB ETF has now led to a clear B2 reversal buy signal. Traders take note!
The Move in iShares Nasdaq Biotechnology Index (ETF) (IBB) ETF Is Coming — Get on Board
Chasing equity markets at these levels is risky. But I can instead use this play in the IBB ETF with a 15% buffer to create income.
iShares Nasdaq Biotechnology Index (ETF) (IBB): The Quick Guide to IBB
The $8 billion-plus iShares Nasdaq Biotechnology ETF (IBB) has a deep bench relative to other biotechnology funds. Is IBB right for you?
Go Long the iShares Nasdaq Biotechnology Index (ETF) (IBB) ETF With Confidence
The healthcare sector, after being the whipping boy of the elections, can find footing. Sell downside risk in the IBB ETF for easy income.
IShares Nasdaq Biotechnology Index (ETF) (IBB): Short the Near-Term Action in the IBB ETF
Drug stocks have been hated by traders for more than a year, but that feeling is abating. Use long-term value to short IBB over the near term.
